(-1.44%) 4 998.77 points
(-1.71%) 37 804 points
(-1.94%) 15 408 points
(-0.47%) $82.42
(-1.63%) $1.626
(-0.22%) $2 333.30
(-0.46%) $27.22
(-0.83%) $908.20
(-0.01%) $0.934
(0.20%) $11.01
(-0.10%) $0.802
(-0.07%) $92.26
Quarter results today
(bmo 2024-04-25)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name...
Stats | |
---|---|
Today's Volume | 38 387.00 |
Average Volume | 28 216.00 |
Market Cap | 402.33M |
EPS | SEK0 ( 2024-02-13 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -5.31 |
ATR14 | SEK0.368 (5.06%) |
Volume Correlation
Medivir AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Medivir AB (publ) Correlation - Currency/Commodity
Medivir AB (publ) Financials
Annual | 2022 |
Revenue: | SEK4.41M |
Gross Profit: | SEK-64.67M (-1 467.11 %) |
EPS: | SEK-1.600 |
Q2 | 2023 |
Revenue: | SEK2.00M |
Gross Profit: | SEK-19.20M (-960.00 %) |
EPS: | SEK-0.480 |
Q1 | 2023 |
Revenue: | SEK400 000 |
Gross Profit: | SEK-12.70M (-3 175.00 %) |
EPS: | SEK-0.330 |
Q4 | 2022 |
Revenue: | SEK2.31M |
Gross Profit: | SEK-13.47M (-583.62 %) |
EPS: | SEK-0.310 |
Financial Reports:
No articles found.
Medivir AB (publ)
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators